FRONTIER CAPITAL MANAGEMENT CO LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 351173
Boston, MA
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,240,115
+$27,917,900 QoQ
Shares Held
254,280
+25.2% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#39
of 500 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $975,847,387 across 22 Biotechnology names. AXSM ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,373,057 | $102,265,285 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,847,936 | $95,092,583 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
740,866 | $84,955,104 | |
| 4 | INSM |
INSMED Inc
|
795,242 | $84,788,702 | |
| 5 | PVLA |
Palvella Therapeutics, Inc.
|
478,833 | $73,175,259 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
277,279 | $66,815,920 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
This page
|
254,280 | $62,240,115 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,070,740 | $57,269,301 |
All Filings in AXSM
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,240,115 | 254,280 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,322,215 | 203,066 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,800,684 | 157,691 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,349,093 | 126,382 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,010,816 | 28,842 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,045,530 | 43,261 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,464,700 | 52,768 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,832,929 | 120,540 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,730,173 | 96,027 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,406,451 | 105,344 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,552,135 | 94,888 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,229,645 | 160,676 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,968,729 | 222,220 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,510,684 | 40,705 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,896,270 | 89,411 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||